Hospital earns accreditation for lung cancer screening : michigansthumb

referring to michigansthumb

Hospital earns accreditation for lung cancer screening

Hospital earns accreditation for lung cancer screening

Bad Axe, MI (48413)TodayConsiderable cloudiness.TonightPartly cloudy skies early will give way to cloudy skies late.A stray shower or thunderstorm is possible.Winds NNE at 10 to 15 mph.


besides eurekalert

Scientists discover new therapeutic target for lung cancer driven by KRAS

Scientists discover new therapeutic target for lung cancer driven by KRAS

DALLAS - July 28, 2016 - UT Southwestern Medical Center researchers have identified a new way to target lung cancer through the KRAS gene, one of the most commonly mutated genes in human cancer and one researchers have so far had difficulty targeting successfully.Researchers studying the underlying biology of KRAS in lung cancer determined that activity resulting from the ACSL3 gene is essential for these lung cancer cells to survive, and that suppressing ACSL3 causes these lung cancer cells to die.The findings are significant because genetic mutations of KRAS occur in about 30 percent of lung cancer cases, and they are associated with aggressive, therapy-resistant disease with a poor prognosis.Lung cancer remains the leading cause of cancer-related deaths in the U.S., according to the National Cancer Institute (NCI).


furthermore eurekalert

Introduction of screening could significantly reduce lung cancer deaths

Introduction of screening could significantly reduce lung cancer deaths

The introduction of lung cancer screening in the UK could significantly reduce deaths in high risk groups, without causing participants the undue stress sometimes associated with medical tests.Published today in Thorax, a trial led by Cardiff University looked at long-term psychosocial outcomes of CT screening for lung cancer and found that it did not cause unnecessary anxiety, even though fear and stigma can sometimes be barriers to participation in screening.Lung cancer is the leading cause of cancer-related mortality in the UK, killing almost 40,000 people per year.Additionally, around three quarters of patients are diagnosed at a late stage when fewer treatment options are available.